Real-time insights. Smarter decisions. Better trades.
🔍 Search Stocks 14 day Free Trial
RACURA ONCOLOGY LTD (RAC)ASX AI Signals has generated 1 signal(s) for RAC during the last 90 days, indicating Moderate trading activity
Latest RAC Signals | |
| 11/06/2026 | SELL |
RAC Share Price | |
| Current Price | $2.290 |
| 52 Week High | $4.700 |
| 52 Week Low: | $1.135 |
| Trading at (% of 52 Week High) | 48.72% |
Racura Oncology Ltd (ASX: RAC) is a biotechnology company focused on developing innovative cancer treatments. The company specializes in advancing immuno-oncology therapies aimed at improving patient outcomes in various types of cancer.
The Pharmaceuticals, Biotechnology & Life Sciences sector on the ASX includes companies involved in the development, production, and commercialization of drugs, medical devices, and biotechnology products. This sector covers activities such as research and development of new medicines, genetic testing, and innovative healthcare technologies. Companies often work on treatments for diseases, including cancer, infectious diseases, and chronic conditions. The sector plays a crucial role in advancing medical science and improving patient care through innovation.
The SELL recommendation for RACURA ONCOLOGY LTD is supported by current price trends and underlying market signals indicating potential downside risk. However, some volatility in the oncology sector and recent company developments warrant a cautious approach.
As the Australian market navigates a mixed landscape with sectors like Materials showing strength while Energy struggles, investors are keenly observing potential opportunities. Penny stocks, though an older term, still represent an intriguing area of investment by highlighting smaller or less-estab The Australian market is navigating a period of volatility following the Federal Reserve's decision to cut interest rates in the U.S., with local shares trending downward and futures for the ASX 200 suggesting a slight loss at open. Despite these broader market fluctuations, penny stocks remain an i The Australian market is showing resilience with a slight recovery on the horizon, as shares trend towards a +0.3% advance despite recent volatility in U.S. tech stocks. Penny stocks, though often considered speculative, can offer intriguing opportunities when backed by strong financials and growth Latest RACURA ONCOLOGY LTD(RAC) News
ASX Penny Stocks To Watch In December 2025
ASX Penny Stocks To Watch In September 2025
3 ASX Penny Stocks Under A$2B Market Cap To Watch
Get access to daily BUY & SELL signals, advanced AI analysis, watchlists and email alerts.
14 Day Free Trial • Cancel Anytime • Founders Price $15/month
Start My Free Trial